Illumina lowers outlook due to China sales ban, to cut $100 million in costs
Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban ...
Trade War Fallout Prompts San Diego's Illumina to Lower Outlook, Cut $100 Million in Costs
Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban ...
Illumina lowers guidance, cuts spending to mitigate China ban on its gene sequencers
Illumina lowered its adjusted profit outlook and cut spending cost for 2025 as the company grapples with Chinese ban on its ...
Fierce Biotech4d
Illumina aims to cut $100M in costs following China import ban
Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...
Illumina to cut $100M in costs to cope with China ban
The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.
Diagnostic Kit Maker Illumina To Cut $100 Million In Costs, Lowers 2025 Profit Outlook Amid China Trade Restrictions
Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...
Investing3d
Illumina’s SWOT analysis: next-gen sequencing leader faces headwinds
Illumina Inc. (NASDAQ:ILMN), a leading provider of next-generation sequencing (NGS) technology with annual revenue of $4.37 billion, finds itself at a critical juncture as it navigates a shifting ...
Yahoo Finance5d
Illumina lowers outlook due to China sales ban, to cut $100 million in costs
(Reuters) -Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban on imports of its genetic sequencing instruments. The ...